FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

VTRS

ViatrisNASDAQ · Pharmaceuticals · Health Care
Previous close
17.02
Change
+0.37 / +2.22%
FinDog View
Neutral
52-Week Range
9.43 – 18.39
P/E (TTM)
—
Forward P/E
7.0
Based on consensus earnings for the next 12 months
Market Cap
$20.7B
1M
+4.87%
S&P 500 −2.41% over same period
Volume / Avg Volume
8.6M / 7.6M
1.13× average

Price History

Closing price · USD1M6M1Y5Y
1616.316.516.81717.32026-082026-082026-092026-092026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-08-06$3.7B0.69 / 0.61+0.86%Read analysis →
FY2026 Q1
Quarter ended 2026-03
2026-05-07$3.5B0.59 / 0.51−1.27%Pending
FY2025 Q4
Quarter ended 2025-12
2026-02-26—— / —−2.10%Pending
FY2025 Q3
Quarter ended 2025-09
2025-11-06—— / —+0.10%Pending
FY2025 Q2
Quarter ended 2025-06
2025-08-07—— / —+3.30%Pending
FY2025 Q1
Quarter ended 2025-03
2025-05-08—— / —−3.52%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
A 5-year P/E range needs a longer earnings record; not yet comparable
Last 4 quarters: $303M in buybacks + $0 in dividends, 1.46% of market cap combined
P/E (TTM)
—
P/B
1.3
P/S
1.3
Dividend Yield
2.70%
Earnings Reaction
Over the last 6 reports, the stock moved ±1.9% on average on the first trading day after, rising 3 times
Most recent +0.86%
Volatility & Correlation
1-year beta 0.73 · Correlation with S&P 500 0.29Tracks the market
Annualized volatility 32% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 1 · $0.81MNet selling $0.81M
  • 06-25Campbell PaulSee RemarksSell$0.81M50,076 shares · Avg price 16.17
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q23.75+5.0%38.6%0.01—0.33-0.10
FY2026 Q13.51+8.2%32.8%-0.08—0.350.15
FY2025 Q43.69+5.0%30.8%-0.19—0.62-0.34
FY2025 Q33.75+0.3%36.3%0.18—0.66-0.11
FY2025 Q23.57−5.7%37.0%0.23—0.170.00
FY2025 Q13.24−11.2%35.5%-2.88—0.49-2.55
FY2024 Q43.52−8.1%34.2%-0.18—0.34-0.43
FY2024 Q33.74−5.0%38.7%0.23—0.750.08
FY2024 Q23.79−3.2%37.9%-0.24—0.32-0.27
FY2024 Q13.65−1.8%40.9%0.20—0.560.09
FY2023 Q43.83−1.1%41.4%-0.45—0.40-0.63
FY2023 Q33.93−3.3%42.8%0.45—0.740.27

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
VTRSViatris$20.7B—+5.0%38.6%+4.87%Neutral
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare